Cell line · CVCL_0032
Papers109
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
1 to 20 of 109
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Dioscin Promotes Ferroptosis in Cervical Cancer Cells via the TIGAR-ROS Axis. | Cancer Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting the KIFC1-SRSF3-PKM Axis Suppresses Cervical Cancer Glycolysis and Enhances Radiosensitivity. | J Cell Mol Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Elevated neutrophil extracellular traps formation driven by the HPV-mediated CXCL8-CXCR1/2-ROS-p21 axis promotes the growth and metastasis of cervical cancer. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Deciphering HPV-Associated Immune Evasion in Cervical Cancer Through Multi-Omics Profiling and Computational Screening. | Anal Cell Pathol (Amst) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Comparative Evaluation of the Cytotoxic Effect of Dysphania ambrosioides Extracts Against Human Breast and Cervical Cancer Cells. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| GATA3 Inhibits the Expression of Viral E6/E7 Genes, and Its Expression Is Compromised During HPV-Mediated Cervical Carcinogenesis. | J Med Virol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| GO-Y078 Triggers Program Cell Death in Human Cervical Cancer Cells Via MAPK Activation-Dependent Apoptotic Caspases Signaling. | Integr Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
Dual-specificity phosphatase 14 inhibits the growth of cervical cancer cells by regulating the transforming growth factor-beta-activated kinase 1 and NOD-like receptor pyrin domain containing 3 inflammatory pathways. | J Int Med Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy. | Neoplasia | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting cell membrane sphingolipids: a novel ceramide analog CeY-B1 inhibits migration and invasion in cervical cancer cells. | J Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The cooperative regulation of miR-221 by APE1 and AUF1 impacts p27Kip1 defining a miR signature relevant for cervical cancer. | FEBS Open Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| M5C-driven stabilization of SERPINB5 promotes cervical cancer progression and chemotherapy resistance. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Development of a novel multi-locus Flow-FISH based assay for detection of progressive cervical precancer lesions. | BMC Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Three-subtype Molecular model of Cervical Cancer: Multiple PI3K Pathway inhibitors suppress growth and cooperate with HPV-directed immunotherapy. | medRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeted modulation of IGFL2-AS1 reveals its translational potential in cervical adenocarcinoma. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TENT5A Maintains MYC mRNA Stability to Enhance Osteosarcoma Stemness. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Alkyltriphenylphosphonium Binding to Cardiolipin Triggers Oncosis in Cancer Cells. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2-dependent manner. | Int J Cancer | 2026 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0032/papers